HCPs Are Cautiously Optimistic About Telehealth
Psychiatrists, oncologists most likely to use telemedicine; ophthalmologists, allergists least likely
CONSHOHOCKEN, Pa. – A new survey conducted by Fingerpaint, a full-service health and wellness marketing agency, about the use of telemedicine shows that a majority (76%) of healthcare practitioners (HCPs) agree it is convenient for their patient, but most (64%) think it is not as effective as engaging with their patient in an office. The survey also shows that adoption and future use of telehealth could greatly depend on the area of practice.
Of those surveyed, 72% said they are currently using telehealth to communicate with their patients, and just over half (58%) said they intend to continue using telemedicine more than they had previously, even after the restrictions associated with COVID-19 are lifted.
“While HCPs are turning to telemedicine out of necessity to offer safe and convenient access to care for their patients and still have some skepticism, they are acknowledging opportunities for continued expanded use post COVID-19,” said Michelle Petroff, head of Fingerpaint’s Conshohocken office. “Brands have the opportunity to be true partners and develop educational information to help HCPs and patients become more comfortable with telehealth.”
Although the survey was not powered to conclude differences, the agency did observe divergence in responses across various specialties.
When broken down by specialty, psychiatrists seem to be the most comfortable with and most receptive to telemedicine, which allows them to interact with their patients much like they would in an office setting without greatly impeding their evaluation. Oncologists also seem to be high adopters of telemedicine and are still incredibly busy with patient load. They are turning to the service out of necessity.
Conversely, ophthalmologists and allergists seem to be having the toughest time converting to telemedicine. These specialties both require close visual examination and specialized tools that cannot easily be completed or used through webcams and phone screens.
The survey link was sent in an email to about 16,000 contacts. Respondents were screened to ensure their status as healthcare professionals who reside in the United States, are board-certified in their specialty, and have a minimum of 4 years’ and maximum of 30 years’ practice experience. A total of 100 healthcare professionals completed the online survey during the week of April 6, 2020.
Reset your expectations of a health and wellness agency. Independent by design, with integrated talent across five offices in New York, Pennsylvania, Arizona, New Jersey, and California, Fingerpaint is committed to creating and executing meaningful brand experiences that are never paint by number for healthcare providers, care partners, and patients.
In 2020, Fingerpaint acquired 1798, a market access and commercialization firm located in La Jolla, Calif., adding to its portfolio of services in support of biopharma customers. Fingerpaint was named 2019 Agency of the Year by Med Ad News, and in 2018, it won the Heart Award from Med Ad News for its commitment to philanthropy and social causes. Additionally, it has been on Inc. Magazine’s list of the 5,000 Fastest-Growing Companies for the past seven years. Founder Ed Mitzen was honored as 2016’s Industry Person of the Year by Med Ad News. Visit us at fingerpaint.com and follow us on Facebook, Twitter, LinkedIn, and Instagram.